AIDX (20/20 Biolabs) Dividends per Share: $0.00 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AIDX 20/20 Biolabs Inc AIDX
6 GF Score
Price $0.43
! 1 Warning Sign
View Full Analysis

What is 20/20 Biolabs Dividends per Share?

20/20 Biolabs AIDX -0.23% 6 Dividends per Share is $0.00 as of Mar. 2026. GuruFocus rates AIDX with a GF Score™ of 6/100. The stock has 1 warning sign investors should review.

20/20 Biolabs's dividends per share for the three months ended in Mar. 2026 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, 20/20 Biolabs's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

20/20 Biolabs  (NAS:AIDX) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

20/20 Biolabs's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ -0.261
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

20/20 Biolabs Dividends per Share Related Terms

20/20 Biolabs Dividends per Share Historical Data

* Premium members only.

The historical data trend for 20/20 Biolabs's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

20/20 Biolabs Dividends per Share Chart

20/20 Biolabs Annual Data
Trend Dec23 Dec24 Dec25
Dividends per Share
0.00 0.00 0.00

20/20 Biolabs Quarterly Data
Dec23 Dec24 Mar25 Sep25 Dec25 Mar26
Dividends per Share Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

AIDX vs STME, TRIB, VVOS: Dividends per Share Comparison

For the Medical Devices subindustry, 20/20 Biolabs's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

20/20 Biolabs Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 20/20 Biolabs's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where 20/20 Biolabs's Dividend Yield % falls into.


AIDX
6GF Score
20/20 Biolabs Inc AIDX
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

20/20 Biolabs Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of $0.00 mean?
20/20 Biolabs (AIDX) has a Dividends per Share of $0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on 20/20 Biolabs and its competitors.
Is 20/20 Biolabs' Dividends per Share too high?
20/20 Biolabs' current Dividends per Share is $0.00. Overall, 20/20 Biolabs has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does 20/20 Biolabs' Dividends per Share compare to STME and TRIB?
20/20 Biolabs' Dividends per Share of $0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Medical Devices & Instruments company?
A good Dividends per Share depends on the Medical Devices & Instruments industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on 20/20 Biolabs and its competitors. 20/20 Biolabs's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 20/20 Biolabs stock overvalued right now?
20/20 Biolabs (AIDX) has a current Dividends per Share of $0.00. The current Dividends per Share is $0.00. 20/20 Biolabs' overall GF Score™ is 6/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For 20/20 Biolabs (AIDX), the current Dividends per Share is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

20/20 Biolabs Business Description

Address 15810 Gaither Road, Suite 235, Gaithersburg, MD, USA, 20877
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
6GF Score

Get the complete analysis for AIDX

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.43
Price